KraneShares MSCI All China Health Care Index ETF (KURE)
NYSEARCA: KUREKraneSharesGreater China RegionETFUSD
At close: Oct 9, 3:59 PM ET · Delayed 15 min
KURE chart
Full chartKey facts
- Expense ratio
- 0.65%
- Assets (AUM)
- $114.38M
- Dividend yield
- 3.69%
- Holdings
- 10
- Inception
- Jan 31, 2018
- Issuer
- KraneShares
- Index tracked
- —
- Category
- Greater China Region
- 52-week range
- 14.38 – 19.93
- Volume / Avg
- 95.48K / 69.40K
- Beta
- —
- Previous close
- 18.64
KURE ETF today
The KraneShares MSCI All China Health Care Index ETF (KURE) is an exchange-traded fund from KraneShares in the Greater China Region category. It charges an expense ratio of 0.65%, or $65.00 per year on a $10,000 investment, and manages $114.4 million in assets. Its largest holding is BeOne Medicines Ltd Ordinary Shares (6160.HK) at 8.83% of assets, and the top 10 positions make up 55.8% of the portfolio out of 10 holdings.
The fund's trailing dividend yield is 3.69% ($0.00 per share annually). KURE launched on Jan 31, 2018.
Summary generated from market data by MetaCap's automated system. Methodology
KURE top 10 holdings
| # | Holding | Weight |
|---|---|---|
| 1 | 6160.HKBeOne Medicines Ltd Ordinary Shares | 8.83% |
| 2 | 1801.HKInnovent Biologics Inc | 8.56% |
| 3 | 2269.HKWuXi Biologics (Cayman) Inc | 8.05% |
| 4 | 603259.SSWuxi AppTec Co Ltd Class A | 5.79% |
| 5 | 9926.HKAkeso Inc Ordinary Shares | 4.67% |
| 6 | 600276.SSJiangsu Hengrui Pharmaceuticals Co Ltd Class A | 4.46% |
| 7 | 300760.SZShenzhen Mindray Bio-Medical Electronics Co Ltd Class A | 4.37% |
| 8 | 1093.HKCSPC Pharmaceutical Group Ltd | 3.77% |
| 9 | 1177.HKSino Biopharmaceutical Ltd | 3.74% |
| 10 | 1548.HKGenscript Biotech Corp Class H | 3.61% |
Top 10 holdings: 55.8% of assets.
KURE performance
1 week
-2.04%
KURE price return, excluding dividends.
ETFs similar to KURE
KURE ETF FAQ
What is the KURE price today?
KURE last traded at $18.72 as of Oct 9, 3:59 PM EDT, up 0.43% on the day.
What is KURE's expense ratio?
KURE has an expense ratio of 0.65%, which works out to about $65.00 per year for every $10,000 invested.
What are KURE's top holdings?
KURE's largest holdings are BeOne Medicines Ltd Ordinary Shares (8.83%), Innovent Biologics Inc (8.56%), WuXi Biologics (Cayman) Inc (8.05%), Wuxi AppTec Co Ltd Class A (5.79%), Akeso Inc Ordinary Shares (4.67%). The top 10 make up 55.8% of the fund.
Does KURE pay a dividend?
Yes. KURE has a trailing dividend yield of 3.69%.
How big is KURE?
KURE has about $114.4 million in assets under management spread across 10 holdings.